Literature DB >> 12142317

Cholestatic hepatitis in association with celecoxib. Classification of drug associated liver dysfunction is questionable.

Faiyaz Mohammed, Alastair D Smith.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12142317      PMCID: PMC1123730          DOI: 10.1136/bmj.325.7357.220

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


× No keyword cloud information.
  7 in total

1.  Celecoxib-induced cholestatic hepatitis.

Authors:  M V Galan; S C Gordon; A L Silverman
Journal:  Ann Intern Med       Date:  2001-02-06       Impact factor: 25.391

Review 2.  Acute hepatocellular and cholestatic injury in a patient taking celecoxib.

Authors:  S Nachimuthu; L Volfinzon; L Gopal
Journal:  Postgrad Med J       Date:  2001-08       Impact factor: 2.401

3.  Drug Points: Cholestatic hepatitis in association with celecoxib.

Authors:  J P O'Beirne; S R Cairns
Journal:  BMJ       Date:  2001-07-07

4.  Rofecoxib-induced cholestatic hepatitis: treatment with molecular adsorbent recycling system (MARS).

Authors:  Dominik Huster; Christian Schubert; Frieder Berr; Joachim Mössner; Karel Caca
Journal:  J Hepatol       Date:  2002-09       Impact factor: 25.083

Review 5.  Criteria of drug-induced liver disorders. Report of an international consensus meeting.

Authors:  C Bénichou
Journal:  J Hepatol       Date:  1990-09       Impact factor: 25.083

Review 6.  The hepatic safety and tolerability of the novel cyclooxygenase-2 inhibitor celecoxib.

Authors:  W C Maddrey; C J Maurath; K M Verburg; G S Geis
Journal:  Am J Ther       Date:  2000-05       Impact factor: 2.688

7.  Hepatic reactions associated with ketoconazole in the United Kingdom.

Authors:  G Lake-Bakaar; P J Scheuer; S Sherlock
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-14
  7 in total
  1 in total

1.  Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury.

Authors:  Leihong Wu; Zhichao Liu; Scott Auerbach; Ruili Huang; Minjun Chen; Kristin McEuen; Joshua Xu; Hong Fang; Weida Tong
Journal:  J Chem Inf Model       Date:  2017-04-10       Impact factor: 4.956

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.